Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04232566

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.

Conditions

Interventions

TypeNameDescription
PROCEDUREBariatric surgeryEvaluate liver fibrosis by elastography before gastric bypass surgery.

Timeline

Start date
2022-02-20
Primary completion
2025-12-31
Completion
2027-12-30
First posted
2020-01-18
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04232566. Inclusion in this directory is not an endorsement.

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity (NCT04232566) · Clinical Trials Directory